图片: | |
---|---|
名称: | |
描述: | |
lfl001200546 离线
姓 名: | ××× | 性别: | 年龄: | ||
标本名称: | 女,50岁,发现外阴肿块3月1.5*1CM | ||||
简要病史: | |||||
肉眼检查: |
liziqiang88 离线
翻译如下:
似乎在这里见到的基底细胞癌比我整个病理从业以来都见得多。我要指出一些诊断“外阴基底细胞癌”的观点。那就是,做出如此少见的诊断之前,需要做一个深呼吸。外阴BBC极其少见,占所有外阴恶性肿瘤的2%。绝大多数(>95%)外阴癌是鳞状细胞癌。我们知道BBC和SCC的预后有很大不同。大多数BBC是局灶性的癌,很少有转移潜能。相反,外阴BBC有很大的转移潜能。因此,诊断外阴BBC时,你基本上是在告诉临床医生和患者“局部切除BBC后你就没事啦!”。既然你很可能面对的是一个局灶的基底样SCC,而不是角化性BCC,这样处理就有很大风险!因此,当你的病例兼有SCC和BCC的特征时,如果不能确信该倒向哪一边,应该偏向于SCC,而不是BCC!
现在我想分享一个我们医院最近的痛苦教训。一名老年女性患者因外阴瘙痒和小于1cm的结节伴表面溃疡而到皮肤科就诊。活检送给了皮肤病理医生,而不是妇科病理医生。皮肤病理医生诊断为外阴BCC伴局灶角质形成。进行了病变局部切除。一年后,患者回来,发现腹股沟淋巴结和盆腔淋巴结转移。猜猜腹股沟淋巴结活检诊断?角化性鳞状细胞癌!!!当妇科病理医生复习原切片时,我们全部认为它是外阴SCC伴部分基底样特征,不是BCC!我希望我们所有人能从这一惨痛教训中获取经验。即:1)当你像cavelier那样作出“外阴BCC”之前,要做深呼吸!2)当你有任何疑问或犹豫时,你需要确信自己已经完全排除了外阴SCC!3)如果不得不签发报告,又不确信倒向哪边,诊断SCC而不是BCC!统计学上你倒在正确一边的概率是95%。
再次强调,对我来说,病理不仅是拿几张照片或切片然后让所有人猜这个诊断什么。临床和病理知识相关的深厚基础,是成为病理大家的前提。两周之前,郑文新博士和我以及Dr. Hatch (美国妇科肿瘤协会主席) and Dr. Belinson (世界知名妇科肿瘤学家和前任Cleveland临床中心妇科主席)以及一些国内妇科肿瘤学家一起在北京大学、复旦大学和中山大学作“肿瘤论坛或临床病理关系讨论”报告。目的就是强调病理学家和临床医生之间的紧密联系。这次讨论中我学到很多,也理解了以前没有理解的与临床医生特别是国内临床医生交流时遇到的很多问题。我鼓励这里所有病理医生与临床同行之间进行越来越多的互动合作,诊断不能仅仅依靠形态学,而是要整合生物学和临床管理。
华夏病理/粉蓝医疗
为基层医院病理科提供全面解决方案,
努力让人人享有便捷准确可靠的病理诊断服务。
以下是引用lfl001200546在2009-3-5 22:17:00的发言: 诊断:角化型基底细胞癌 |
It seems that we have seen more basal cell carcinoma of the vulva here than my whole pathology career. I want to make a few points about making diagnosis of " Vulva Basal Cell Carcinoma". That is, you need have a deep breath before you make such a very unusual diagnosis. Vulva BCC is vanishingly rare, counts about 2% of all vulva malignancy. Vast majority (>95%)of vulva cancer is squamous cell carcinoma. We all know the prognosis between BCC and SCC is dramatically different. Most BCCs are local cancer with minimal potential to metastasize. In contrast, vulva SCC has great potential to metastasize. Therefore, when you make a diagnosis of vulva BCC, you basically tell clinicians and this patient: " You are fine after local resection of your BCC!". That is very risk approach since you most likely deal with a focal basaloid SCC, not a keratinizing BCC! Therefore, when you have a case sharing features between SCC and BCC, if you are not sure which side you should lean on, you should air on the side of SCC, not the BCC!
Now I like to share a painful mistake in our hospital recently. A older female patient went to dermatology clinic due to vulva itching and a about less than 1.0 CM nodule with superficial ulceration. Biopsy was sent to dermatopathologist, not GYN pathologist. Dermatopathologist made a diagnosis of vulvar BCC with focal keratin formation. Local excision of this lesion is done. A year later, the patient came back with inguinal LN metastasis and pelvic LN metastasis. Guess what is diagnosis of biopsy of inguical LN? KERATINIZING SQUAMOUS CELL CARCINOMA!!! When GYN pathologists re-reviewed the previous biopsy, we all agree it was a vulva SCC with some kind of basaloid feature, NOT a BCC! I hope we all can learn lessons from this painful story! That is: 1) Have a deep breath before you act like a cavelier to render your diagnosis of "Vulva Basal Cell Carcinoma"! 2) If you have any question or hesitation, you need make sure you have totally rule out a vulva squamous cell carcinoma! 3) If you have to rush the case and are not sure which way to go, making a diagnosis of SCC rather than BCC! Statistically you have 95% of chance on the right side.
Again, pathology to me is not just toss couple photos or slides and everybody guess what the diagnosis is! A sound knowledge of clinical and pathological correlation is the foundation to be a great pathologist! Couple weeks ago, Dr. Wenxin Zheng and I along with Dr. Hatch (president of American Society of Gynecologic Oncology) and Dr. Belinson (a world-renown gynecologic oncologist and our previous Chairman of GYN Department at Cleveland Clinic)gave several "Tumor Boards or CLinicopathologic Correlation Conference" in Peking University, Fudan University and Zhongshan University along with Chinese genecologic oncologists. The purpose is to strengthen the close tie between pathologists and clinicians. I have learned a great deal in participating in such discussion and understand lot of issues I did not understand before by communicating with clinicians, especially Chinese clinicians. I encourage all pathologists here to get more and more interaction with clinical colleagues and making diagnosis not only based on morphology, but integrating biology and clinical management into our decision making process.
lfl001200546 离线
huisheng97 离线